Log in to save to my catalogue

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or pac...

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or pac...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2641706359

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

About this item

Full title

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

Publisher

New York: Nature Publishing Group US

Journal title

Cancer gene therapy, 2002-05, Vol.9 (5), p.478-481

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

More information

Scope and Contents

Contents

A mouse model of human ovarian cancer was used to investigate the effect of adenovirus-mediated thymidine kinase gene therapy (gt) in combination with chemotherapy. One hundred sixty female CD-1 nu/nu mice were injected intraperitoneally with Ov-ca-2774 cells. Onset of intraperitoneal treatment with either topotecan (6 or 12 mg/kg) or paclitaxel (1...

Alternative Titles

Full title

Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2641706359

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2641706359

Other Identifiers

ISSN

0929-1903

E-ISSN

1476-5500

DOI

10.1038/sj.cgt.7700462

How to access this item